Back to Insulin research
insulin glp 1 agonist rct 2020-11-02 ClinicalTrials

Oral Semaglutide Shows Promise for Pediatric Type 2 Diabetes Management

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

Background

Type 2 Diabetes is an escalating health concern in children and adolescents, leading to severe long-term complications. While effective injectable treatments exist for adults, there's a significant lack of convenient and effective oral treatment options specifically tailored for this younger population. This Phase 3 study investigates the efficacy and safety of an oral form of semaglutide to address this critical unmet need.


insulin semaglutide glp 1 agonist glp-1r protocol relevant
Source: clinicaltrials:NCT04596631 · Ingested 2026-04-21 · Digest: gemini-2.5-flash